<p><b>A</b>. Volcano plot analysis (integrating p-values and log2 foldchanges) for the LPS-induced response in subjects treated with placebo. <b>B</b>. Volcano plot analysis of the LPS-induced response in subjects treated with the TNFα antagonist etanercept. Red dots in panels A and B indicate probes that showed a fold-change ≥1.5 or ≤1.5. <b>C</b>. Unsupervised hierarchical clustering heatmap of the 4077 LPS-induced transcripts that were influenced by etanercept treatment as identified by ANOVA (q-value <0.05). Columns represent subject samples and rows represent transcripts. Red indicates increased gene expression, and blue indicates decreased gene expression.</p
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p>Fold-changes of gene expression are relative to normal (NL) controls on day 11. NSAID treatment s...
The global transcriptional change across the groups compared was visualized by a volcano plot (A) wi...
TNFα has been implicated in the pathogenesis of various inflammatory diseases. Different strategies ...
<p>Genes within LPS-induced TNFα responsive co-expression modules possessing epigenetic regulation, ...
TNFa has been implicated in the pathogenesis of various inflammatory diseases. Different strategies ...
<p>For each plot, fold change in expression for each of the inflammatory cytokines studied (<a href=...
<p>Gene expression analysis of human monocytes stimulated with LPS, ibuprofen, Pep and combinations ...
<p>Volcano plots are scatter plots of the log<sub>2</sub> fold change against the negative log<sub>2...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p><i>Green dots</i> indicate down-regulated genes and <i>red dots</i> indicate up-regulated genes. ...
<p>Results from Gene Ontology analysis of data set retrieved from 1W-ANOVA. (A) List of genes belong...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p>Effect of CGA (25 μM, 50 μM), Lp 2142 SCS (13.3%) and combined treatment (CGA 25 μM and Lp 2142 S...
<p>A) A RA-perturbed networks showing the recovery of the elevated RAGs to normality by anti-TNF the...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p>Fold-changes of gene expression are relative to normal (NL) controls on day 11. NSAID treatment s...
The global transcriptional change across the groups compared was visualized by a volcano plot (A) wi...
TNFα has been implicated in the pathogenesis of various inflammatory diseases. Different strategies ...
<p>Genes within LPS-induced TNFα responsive co-expression modules possessing epigenetic regulation, ...
TNFa has been implicated in the pathogenesis of various inflammatory diseases. Different strategies ...
<p>For each plot, fold change in expression for each of the inflammatory cytokines studied (<a href=...
<p>Gene expression analysis of human monocytes stimulated with LPS, ibuprofen, Pep and combinations ...
<p>Volcano plots are scatter plots of the log<sub>2</sub> fold change against the negative log<sub>2...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p><i>Green dots</i> indicate down-regulated genes and <i>red dots</i> indicate up-regulated genes. ...
<p>Results from Gene Ontology analysis of data set retrieved from 1W-ANOVA. (A) List of genes belong...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p>Effect of CGA (25 μM, 50 μM), Lp 2142 SCS (13.3%) and combined treatment (CGA 25 μM and Lp 2142 S...
<p>A) A RA-perturbed networks showing the recovery of the elevated RAGs to normality by anti-TNF the...
Systemic autoinflammatory diseases (SAIDs) are a group of rare diseases characterized by recurrent o...
<p>Fold-changes of gene expression are relative to normal (NL) controls on day 11. NSAID treatment s...
The global transcriptional change across the groups compared was visualized by a volcano plot (A) wi...